All Stories

  1. The role of biosimilars in value-based oncology care

    Article • Cancer Management and Research, October 2018, Dove Medical Press

    Dr. Luiz H Arantes Jr.

  2. A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia

    Article • Critical Reviews in Oncology/Hematology, September 2018, Elsevier

    Dr. Luiz H Arantes Jr., Dr Vincent Launay-Vacher

  3. Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America

    Article • mAbs, August 2018, Taylor & Francis

    Dr. Luiz H Arantes Jr.